We seek wild precision for the Nutraceutical industry by developing pristine bioactive botanicals, using indoor farming.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Ghislenghien
State: Hainaut
Zip:
Country: Belgium
OUR MISSION We are Botanical Explorers seeking the next frontier of plant health benefits while preserving wild biotopes. We firmly believe that medicinal plants deserve a new standard of uncompromising quality, and we are committed to explore their health potential further while respecting the planet. Hence, our two core values: Explore &a; Respect. OUR VISION Indoor Precision Farming offers a unique opportunity to sustainably grow potent medicinal plants. We have developed our own indoor farming approach under ultra-clean conditions. Our cultivation facilities are one of the largest vertical farms in Europe. There, by optimizing the growth environment, we ensure that our botanicals reach their full potential in terms of Health benefits, bringing full-spectrum product to the next level, and combining Wild Quality with Lab purity. OUR PRODUCT With more than 3000 years of medicinal tradition and more than 5000 scientific publications about its health benefits, Korean red ginseng (Panax ginseng CA Meyer) is, without a doubt, the most precious and revered medicinal plant in the world. At BOTALYS, we are shaping its molecular profile, making our full-spectrum ginseng root powder comparable to a 20 years old wild Korean ginseng specimen. And ginseng is just the first botanical milestone of our journey…
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2020 | Series B | 3 | $5.6M |
S.R.I.W. Vives Louvain Technology Fund WapInvest S.R.I.W. Vives Louvain Technology Fund WapInvest |
8/2014 | Seed Round | 1 | $367.5k |
WapInvest |
1/2018 | Series A | 1 | $555.2k |
Vives Louvain Technology Fund |
7/2016 | Seed Round | $636.9k | 3/2019 | Grant | 1 | $2.5M |
Horizon 2020 Horizon 2020 |
12/2018 | Series A | 1 | $1.3M |
Vives Louvain Technology Fund |
10/2022 | Series B | 4 | $6.6M |
Air Liquide ALIAD S.R.I.W. The Yield Lab Europe WapInvest Air Liquide ALIAD S.R.I.W. The Yield Lab Europe WapInvest |
10/2022 | Convertible Note | 3 | $898.5k |
S.R.I.W. Vives Louvain Technology Fund WapInvest S.R.I.W. Vives Louvain Technology Fund WapInvest |
3/2011 | Pre Seed Round | $97.1k | 4/2019 | Series A | 1 | $969.7k |
Vives Louvain Technology Fund Vives Louvain Technology Fund |
10/2022 | Secondary Market | 4 | $246.8k |
Air Liquide ALIAD S.R.I.W. The Yield Lab Europe WapInvest Air Liquide ALIAD S.R.I.W. The Yield Lab Europe WapInvest |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|